News Conference News VIVA 2016 Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option L.A. McKeown October 12, 2016
News Conference News VIVA 2016 Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions L.A. McKeown September 22, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016
News Conference News VIVA 2016 Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds L.A. McKeown September 21, 2016
News Conference News VIVA 2016 Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent L.A. McKeown September 20, 2016
News Daily News Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD Todd Neale September 13, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News Drug-Coated Balloons Best Suited for In-Stent Restenosis in BMS, not DES Caitlin E. Cox August 17, 2016
News Industry News REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment July 28, 2016
News Industry News Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths July 13, 2016
News Daily News Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed Caitlin E. Cox July 07, 2016
News Daily News A Tight Spot: Drug-Eluting Stents Seem to Top Other Options for Small-Vessel Disease Todd Neale June 16, 2016
News Daily News Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain Todd Neale April 28, 2016
News Daily News IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era Todd Neale March 22, 2016
News Daily News Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding L.A. McKeown March 08, 2016
News Industry News Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent February 24, 2016
News Daily News SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents L.A. McKeown February 16, 2016